NYU Dentistry receives $2.8M grant to spot progression of cavities in children: 5 things to know

Share on Facebook
The National Institute of Dental and Craniofacial Research granted New York University College of Dentistry $2.8 million to study the effectiveness of silver diamine fluoride.

Here are five things to know:

1. The grant is part of a larger $9.8 million study over four years. NYU Dentistry will take part in the Phase III randomized controlled trail.

2. In 2016, the FDA designated silver diamine fluoride a breakthrough therapy, a process which is designed to expedite drug development. This study will provide data for obtaining a cavity arrest drug claim for silver diamine fluoride in the U.S.

3. The study will follow more than 1,000 children, ages two to five years old. Researchers will treat and monitor the children over a school year to study the impact of silver diamine fluoride applied twice over the 12 month calendar year.

4. Additionally, researchers will measure oral health related quality of life and treatment satisfaction and acceptability.

5. NYU Dentistry investigators include Yihong Li, DDS, Courtney Chinn, DDS, and Mark Wolff, DDS.

More articles on dental:
Smile Brands adds to its 360+ supported dental practices: 4 takeaways
LED Medical Diagnostic subsidiary Apteryx integrates with DSN Software bringing DSO software & dental imaging together: 5 insights
Dimensional Dental becomes largest DSO in New Jersey through Brighter Dental affiliation: 5 points

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's Dental Review

Dentsply Sirona, Smile Brands & more: 5 dental companies making headlines

Read Now

Upcoming Events

Top 40 Articles from the Past 6 Months